Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CTi Biopharma Corp (NASDAQ:CTIC)

1.60
Delayed Data
As of Aug 28
 +0.03 / +1.91%
Today’s Change
1.50
Today|||52-Week Range
2.94
-32.20%
Year-to-Date

Today’s Trading

Previous close1.57
Today’s open1.60
Day’s range1.55 - 1.61
Volume920,918
Average volume (3 months)2,936,738
Market cap$289.1M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-51.16%
Earnings growth (this year)+30.77%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+73.24%
P/E ratioNM
Price/Sales5.83
Price/Book6.77

Competitors

 Today’s
change
Today’s
% change
RDNTRadNet Inc-0.17-2.74%
NVTAInvitae Corp+1.44+15.25%
CCMConcord Medical Serv...+0.08+1.58%
NEONeogenomics Inc+0.30+5.02%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$60.1M
Annual profit (last year)-$93.4M
Net profit margin-155.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Bianco
Executive Vice President-Finance &
Administration
Lou A. Bianco
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers